Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

AMLODIPINE BESYLATE AND VALSARTAN

AMLODIPINE BESYLATE; VALSARTAN

Standard Dose
EQ 10MG BASE;160MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview AMLODIPINE BESYLATE AND VALSARTAN is listed in Drugs@FDA under application 207292 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient AMLODIPINE BESYLATE; VALSARTAN Form and strength TABLET;ORAL - EQ 10MG BASE;160MG Sponsor MACLEODS PHARMS LTD Submission history Latest submission status date: 2024-10-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMLODIPINE BESYLATE AND VALSARTAN is listed in Drugs@FDA under application 207292 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AMLODIPINE BESYLATE; VALSARTAN Form and strength TABLET;ORAL - EQ 10MG BASE;160MG Sponsor MACLEODS PHARMS LTD Submission history Latest submission status date: 2024-10-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
AMLODIPINE BESYLATE AND VALSARTAN (AMLODIPINE BESYLATE; VALSARTAN) | Drug Monograph | MedicHelpline